Clinical Trial Update: Efficacy and Safety Study of Nasacort in Chronic Non Allergic and Non Infectious Rhinitis in Adults [Phase 3]

View source ↗

Summary

This update reports the termination of a Phase 3 trial evaluating Nasacort for chronic nonallergic, noninfectious rhinitis in adults.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rhinitis

Drugs mentioned

• Nasacort (triamcinolone acetonide)

Snippet

Sponsor: Sanofi | Conditions: Rhinitis | Phase 3 | Status: TERMINATED